NAFDAC Issues Recall for Batch of Deekins Amoxycillin 500mg Capsules

NAFDAC Issues Recall for Batch of Deekins Amoxycillin 500mg Capsules

By Fly Cable News

The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a batch of Deekins Amoxycillin 500mg Capsules, manufactured by Ecomed Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd. The affected batch, with lot number 4C639001, is being withdrawn following reports of serious adverse drug reactions.

According to Ecomed Pharma Ltd, the recall follows three reported cases of severe adverse reactions in patients who were administered this batch of the antibiotic. Amoxicillin is commonly used to treat bacterial infections such as tonsillitis, bronchitis, pneumonia, and urinary tract infections.

NAFDAC has emphasized that these adverse reactions could be life-threatening, leading to hospitalization, prolonged illness, significant disability, or even death in fatal cases. The product details for the affected batch are as follows: Manufactured by Ecomed Pharma Ltd, with a manufacturing date of March 2024, expiry date of February 2027, and batch number 4C639001.

The agency is urging distributors, healthcare providers, and patients to be vigilant, ensuring that the recalled product is not distributed, administered, or used. It has advised that anyone in possession of the affected batch immediately cease its sale or use and return the stock to the nearest NAFDAC office.

NAFDAC also urges individuals who have used this product or have experienced any adverse reactions to seek medical advice from a healthcare professional. Consumers and healthcare providers are encouraged to report any suspected substandard or falsified medicines to NAFDAC via its contact details or online reporting platform.